CA
NZ
UK
AU
IND
US
A Form 4 filed with the SEC on August 24, 2026, discloses that Aldo J. Polak, a director of EVERTEC, Inc. (NYSE:EVTC), sold 1,000 shares of common stock on August 21, 2026.
Garrett L. Chase, Senior Vice President and Chief Financial Officer of Viasat Inc, filed a statement of changes in beneficial ownership on August 24, 2026, reporting the sale of 4,000 shares of common stock on August 20, 2026, pursuant to a pre-established Rule 10b5-1 …
Fred Joseph Deutsch, Executive Vice President and Director of First Community Corp /SC/, filed a Form 4 on August 24, 2026, reporting the sale of common stock on August 21 and August 24, 2026, as disclosed to the U.S. Securities and Exchange Commission.
Director Paul W. Chung filed a Form 4 with the SEC on August 24, 2026, reporting a disposition of 1,000 shares of Targa Resources Corp. common stock on August 20, 2026, via a gift transaction at a price of $0.
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corporation (NASDAQ:UTHR), filed a Form 4 on August 24, 2026, disclosing the exercise of stock options and subsequent sale of common stock on August 21, 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan.
John M. Leonard, President and CEO of Intellia Therapeutics, Inc. (NASDAQ:NTLA), filed a Form 4 on August 24, 2026, reporting the sale of common stock on August 20 and August 21, 2026, executed automatically under a pre-established Rule 10b5-1 trading plan.
Gregory S. Karawan, EVP and General Counsel of Genworth Financial Inc., filed a Form 4 on August 24, 2026, disclosing the sale of 40,000 shares of common stock on August 21, 2026.
Rogerio Mendonca, President of the Equipment Group at Westinghouse Air Brake Technologies Corp, filed a Form 4 on August 24, 2026, reporting the sale of common stock on August 21, 2026, on behalf of NYSE:WAB.
Kevin R. Sayer, Executive Chair and Director of DexCom Inc (NASDAQ:DXCM), filed a Form 4 on August 24, 2026, reporting the sale of common stock on August 20, 2026, pursuant to a pre-established 10b5-1 trading plan.
Melissa A. Burgum, Chief Accounting Officer of Accenture plc (NYSE:ACN), filed an amended Form 4/A on August 24, 2026, correcting the number of restricted share units reported in an original filing dated August 3, 2026.
Please wait processing your request...